Eyebot

Eyebot (operating at eyebot.co) is a health technology company engineered to expand access to vision care through AI-powered automated solutions. Founded in 2021 and headquartered in Boston, Massachusetts, Eyebot addresses the inefficiencies of traditional eye examinations by offering self-serve vision testing kiosks, known as CarePods, that deliver precision prescriptions with clinical oversight. Under the hood, the platform integrates advanced AI and optical technology to enable freestanding, doctor-verified eye exams in minutes. This allows optical brands and consumers to bypass lengthy in-person appointments while ensuring accuracy and accessibility. Eyebot’s technology powers leading optical retailers, streamlining the transition from prescription to purchase. Backed by top venture capital firms, including General Catalyst, and the National Science Foundation, the company has raised approximately $30 million in funding to fuel partnerships, product innovation, and team expansion across the U.S.